Esperion Therapeutics Announces Positive Top-Line Results from Phase 2 Clinical Study
Inogen CFO Ali Bauerlein Honored with Two Business Awards
Fidelis SeniorCare Closes $20.5 Million Equity Financing
Tangent Medical Named Finalist in 2013 American Business Awards
IntelliCyt Corporation Closes $8 Million in New Financing
Esperion Therapeutics Presents Full Results of Phase 2 Clinical Trial
As Companies Abandon Cholesterol, an Old Player Re-Emerges
Esperion Therapeutics Completes $33 Million Preferred Financing
BAROnova Announces the Results of ENDObesity I Clinical Trial